Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Karyopharm Therapeutics Inc.

OTC: KPTIQ · Life Sciences · 5 alerts · CIK 1503802

Share price
$0.0290Close, Nov 16
Market cap
$658K
Shares outstanding
22.68MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Karyopharm Therapeutics Inc. filings on SEC EDGAR ↗

6:05 AM ET 8-K
Bankruptcy & Restructuring

Karyopharm Therapeutics Bankruptcy & Restructuring

Karyopharm Therapeutics Inc. and its subsidiary filed voluntary petitions for Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court for the Southern District of Texas. The company entered into a Restructuring Support Agreement with 100% of its funded debt holders and Ayrmid Ltd., which will serve as a stalking horse bidder for a merger with the reorganized company. The company will continue operations as a debtor-in-possession while seeking a court-supervised sale or reorganization to maximize stakeholder value.

Counterparty
Ayrmid Ltd.
9:22 AM ET 8-K
Bankruptcy & Restructuring

Karyopharm Therapeutics Bankruptcy & Restructuring

Karyopharm Therapeutics has filed for voluntary Chapter 11 bankruptcy protection to implement a Restructuring Support Agreement and a planned merger with Ayrmid Ltd. The company secured $55 million in debtor-in-possession (DIP) financing to maintain operations during the court-supervised sale process. Existing equity holders are warned that their common and preferred stock will likely have no value and experience a complete loss.

Counterparty
Ayrmid Ltd.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.